NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Can Fin Homes Sees Recovery in Disbursements and Improving Asset Quality

Prabhudas Lilladher's research report highlights a positive trend in Can Fin Homes' 4Q disbursements, driven by a recovery rate in Karnataka and Telangana. The company's loan book saw a 10.5% year-over-year (YoY) growth in Q4, with the research firm expecting a loan growth of 14% in FY27 and 13% in FY28E.

The National Interest Margin (NIM) is expected to trend in line with the company's guidance at 3.75% as the portfolio reprices. Can Fin Homes also has levers to manage an elevated Cost of Funds (CoF). Asset quality trends have been steadily improving, with credit cost guidance remaining benign at approximately 15 basis points (bps) in FY27.

The company's cost/income ratio is expected to be elevated at 18% over FY27-28E due to investments in business transformation and branch expansion. Despite this, the research firm expects a stable margin trajectory.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Estimate Revisions

FY27EFY28E
Loan Growth14%13%
NIM3.75%3.75%
Credit Cost15bps-
Cost/Income Ratio18%18%

Valuation and Recommendation

Based on the revised estimates, Prabhudas Lilladher values the stock at 1.8x March 28, 2028 Price-to-Asset-Based Value (P/ABV), resulting in a Target Price of Rs 1,075. The research firm reiterates a BUY recommendation for Can Fin Homes.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors should consider buying Can Fin Homes with a target price of Rs 1075.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.